Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine Sub-study in Stable Angina Pectoris
NCT03401502Completed
- Sponsor
- TSH Biopharm Corporation Limited
- Start
- Jun 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in stable angina pectoris comparing Ranolazine with Placebo (2 arms). Primary endpoint: Exercise Treadmill Test performing duration at Week 12. Started Jun 2018; status: completed.
02
Drugs
ranolazine
03
Conditions
stable angina pectoris
Beyond the preview
Go deeper on NCT03401502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03401502.